Renaissance Technologies
IOVA icon

Renaissance Technologies’s Iovance Biotherapeutics IOVA Stock Holding History

Renaissance Technologies’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-651,000
Closed -$1.78M – 3461
2025
Q4 		$1.78M Buy
+651,000
New +$1.51M ﹤0.01% 1936
2025
Q3 		– Sell
-4,887,200
Closed -$8.41M – 3695
2025
Q2 		$8.41M Buy
4,887,200
+1,375,800
+39% +$3.42M 0.01% 1179
2025
Q1 		$11.7M Buy
+3,511,400
New +$18.1M 0.02% 926
2023
Q4 		– Sell
-1,226,400
Closed -$5.58M – 3904
2023
Q3 		$5.58M Sell
1,226,400
-506,300
-29% -$3.31M 0.01% 1236
2023
Q2 		$12.2M Sell
1,732,700
-142,800
-8% -$1.02M 0.02% 925
2023
Q1 		$11.5M Sell
1,875,500
-1,325,400
-41% -$9.14M 0.02% 1023
2022
Q4 		$20.5M Buy
3,200,900
+2,392,300
+296% +$18.7M 0.03% 699
2022
Q3 		$7.75M Buy
+808,600
New +$9.33M 0.01% 1166
2022
Q1 		– Sell
-270,000
Closed -$5.15M – 4255
2021
Q4 		$5.15M Buy
+270,000
New +$5.94M 0.01% 1513
2021
Q2 		– Sell
-140,600
Closed -$4.45M – 3616
2021
Q1 		$4.45M Buy
+140,600
New +$5.83M 0.01% 1718
2019
Q4 		– Sell
-61,400
Closed -$1.12M – 3616
2019
Q3 		$1.12M Buy
+61,400
New +$1.36M ﹤0.01% 2553
2016
Q4 		– Sell
-19,000
Closed -$156K – 3344
2016
Q3 		$156K Buy
+19,000
New +$161K ﹤0.01% 3110

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Renaissance Technologies's IOVA Position: Q1 2026 in Review

Renaissance Technologies sold out of Iovance Biotherapeutics (IOVA) in Q1 2026, closing a stake of 651,000 shares — an estimated $1.78M sold.

Renaissance Technologies first reported a position in IOVA in Q3 2016 and held it in 12 quarters. The position peaked at $20.5M in Q4 2022. 286 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Renaissance Technologies reported no remaining Iovance Biotherapeutics position as of Q1 2026 after selling out during the quarter.
  • Renaissance Technologies sold 651,000 Iovance Biotherapeutics shares in Q1 2026, an estimated $1.78M.
  • Renaissance Technologies first reported a position in Iovance Biotherapeutics in Q3 2016 and held it in 12 quarters.
  • Renaissance Technologies's Iovance Biotherapeutics position peaked at $20.5M in Q4 2022.
  • 286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.